Mid-term Results of Hybrid Myocardial Revascolarization for the Patients with the Coronary Arteries Disease

  • A. Gabrielyan Shalimov’s National Institute of Surgery and Transplantation to National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • T. Domansky Shalimov’s National Institute of Surgery and Transplantation to National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • О. Beregovoy Shalimov’s National Institute of Surgery and Transplantation to National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
Keywords: myocardial revascularization, hybrid technique, coronary bypass

Abstract

Introduction. Myocardial revascularization using traditional percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is indicated to the patients with multivessel coronary artery (CA) damage. However, complete revascularization using a single method may not always be possible. Results of the study enrolling 83,695 patients indicate that in the group of patients who underwent complete myocardial revascularization using the PCI and CABG methods, the mortality rate was lower in those who underwent complete myocardial revascularization.

Objective of the study was to analyze the medium-term treatment outcomes in patients with coronary heart disease and multivessel coronary artery damage who underwent PCI and CABG.

Materials and methods. The treatment outcomes in 26 patients undergoing myocardial revascularization by means of combining two methods – percutaneous coronary intervention (PCI) and off-pump CABG – were analyzed. The observation time was 25.0 ± 9.6 months.

Results and discussion. The survey data obtained included the scores of the Seattle Questionnaire developed by Spertus J. et al. [6] and Holter monitoring data. The medium-term results of EchoCG have been analyzed. Medium-term observational results showed 100 % survival rate, 1 (3.8 %) case of myocardial ischemia recurrence, 1 (3.8 %) case of re-revascularization; neurological events were not revealed.

Conclusions. The medium-term results obtained indicate the effectiveness and safety of this approach.

References

  1. Sandoval Y, Brilakis ES, Canoniero M, Yannopoulos D, Garcia S. Complete versus incomplete coronary revascularization of patients with multivessel coronary artery disease. Curr Treat Options Cardiovasc Med. 2015;17:366. https://doi.org/10.1007/s11936-015-0366-1
  2. Zimarino M, Ricci F, Romanello M, Di Nicola M, Corazzini A, De Caterina R. Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies. Catheter Cardiovasc Interv. 2016 Jan 1;87(1):3–12. https://doi.org/10.1002/ccd.25923
  3. Chang M, Ahn JM, Kim N, Lee PH, Roh JH, Yoon SH, et al. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents. Am Heart J. 2016;179:157–65. https://doi.org/10.1016/j.ahj.2016.06.020
  4. Ong AT, Serruys PW. Complete revascularization: coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation. 2006;114:249–55. https://doi.org/10.1161/CIRCULATIONAHA.106.614420
  5. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Fihn SD. Monitoring the quality of life in patients with coronary artery disease. Am. J Cardiol. 1994 Dec 15;74(12):1240–4.
Published
2019-05-22
How to Cite
Gabrielyan, A., Domansky, T., & BeregovoyО. (2019). Mid-term Results of Hybrid Myocardial Revascolarization for the Patients with the Coronary Arteries Disease. Ukrainian Journal of Cardiovascular Surgery, (2 (35), 10-12. https://doi.org/10.30702//ujcvs/19.3505/026010-012